Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

Eastern Regional Medical Center

Status: Withdrawn

Conditions: Peripheral Neuropathy

Study type: Observational

Funder types: Other

Identifiers

NCT02606110

ERMC 14-11

Details and patient eligibility

About

The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with breast cancer referred to Physical Therapy for CIPN
• Physical Therapy Examination indicates use of Rebuilder for CIPN
• At least 18 years of age
• Signed informed consent for study population
• Willingness to complete study according to protocol

Exclusion criteria

• Patients who do not have CIPN
• Patients <18 years of age
• Inability to or unwilling to sign informed consent
• Unable to read and understand the English language
• Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism
• More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy